the primary scientific society fostering research on the basic mechanisms of mutagenesis as well as on the application of this knowledge in the field of genetic toxicology.
Aagami is a Contract Research Organization (CRO) providing its Drug Discovery and Development Services to Pharmaceutical and Biotech industries in early exploratory and full development phases. These services include:
Clinical Trials - Phase I through P
Biological and Cellular Vaccines for phase I /II Clinical Trials. It was granted a Manufacturing Authorisation for Investigational Medicinal Products by the MHRA for the Manufacture of Biologicals in June 2005.
Simcyp provides a platform for modelling and simulation of drug absorption, distribution, metabolism and excretion (ADME) in virtual populations. The Simulator is licensed to our Consortium member clients for use in drug discovery and development.
Cambridge BioScience is a leading distributor in the UK and Ireland of products and services for life science research.
We are one of the longest established companies serving this market and have built a comprehensive product portfolio.
MICROMEDEX is the leading provider of clinical information and decision support tools. MICROMEDEX products are relied upon for their comprehensive drug, toxicology, environmental, regulatory, chemical, MSDS, alternative medicine...
Gene Logic is leading pharmaceutical R&D transformation with its extensive gene expression databases, pioneering efforts in toxicogenomics, sophisticated bioinformatics expertise, nonclinical services capabilities and cutting-edge technology program for d
Advanced Targeting Systems is the world's expert in targeting and eliminating cell types, targeting reagents, immunotoxins, targeted toxins, saporin, monoclonal/polyclonal antibodies, cell targeting antibodies, and custom conjugation services.
Pharmacyclics develops novel small-molecule drugs for brain metastases, lung cancer and other oncology indications. Lead compound Xcytrin (motexafin gadolinium) is in late-stage human clinical trials.
The Institute of Cancer Therapeutics is devoted to the design, synthesis and evaluation of anticancer therapies. The primary objective is cancer medicines development both on a research basis and ona contract fee-for-service basis.
A pioneer in innovative analytical instruments for diagnostics and life sciences research, offers a HPLC systems, specialty detectors, components, accessories, reagents, technical assistance and analytical services to improve the quality of healthcare.
Apredica provides contract research services for the evaluation and optimization of the Absorption, Distribution, Metabolism, Elimination, Toxicity - (ADMET) - and Pharmacokinetic properties of drug candidates early in the drug-discovery process.
Moniliformin is a mycotoxin, formed in many cereals by a number of Fusarium species that include F. avenaceum. F. subglutinans, F. proliferatum and others. Naturally, Moniliformin occurs as sodium or potassium salt of 1-hydroxycyclobut-1-ene-3,4-dione.
ClinicalTrials.gov provides patients, family members, health care professionals, and members of the public easy access to information on clinical trials for a wide range of...
Deciphera Pharmaceuticals designs, optimizes, and introduces small molecule therapeutics for human clinical trials and the global pharmaceutical marketplace.
Syntaxin Ltd is a newly formed biopharmaceutical company focusing on the discovery and development of new medicines derived from bacterial toxins to treat chronic diseases.
